Dr William Jenkins
Appointed to the Board
6 May 2009. Senior Independent Director since 1 September 2011
Dr Jenkins is a non-executive director of Ablynx nv, Allecra Therapeutics GmbH and Apitope International NV. He is also a member of the Scientific Advisory board of BB Biotech Ventures and a member of the Strategic Advisory Board of Chiesi Farmaceutici SpA. He is principal of William Jenkins Pharma Consulting.
William is Chair of the Remuneration Committee and a member of the Nomination Committee.
Skills & Experience
Formerly head of Worldwide Clinical Development and Regulatory Affairs for Novartis Pharma AG and held similar positions with Ciba Geigy AG and Glaxo.